XML 85 R62.htm IDEA: XBRL DOCUMENT v3.10.0.1
Investments in Unconsolidated Affiliates (Details) - USD ($)
1 Months Ended 3 Months Ended 12 Months Ended
Oct. 01, 2018
Dec. 31, 2017
Feb. 28, 2017
Apr. 30, 2016
Jan. 31, 2016
Sep. 30, 2017
Jun. 30, 2017
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Schedule of Equity Method Investments [Line Items]                    
Cash payment for acquisition $ 10,000,000.0                  
Recognized net loss from investment               $ 0 $ 0 $ 1,430,000
Impairment of investments in unconsolidated affiliates               0 2,500,000 0
Losses from equity investment               0 0 468,000
Loss on deconsolidation of subsidiary               0 3,505,000 0
Proceeds from sales of AREC assets   $ 2,800,000           0 2,775,000 0
Receivable   121,353,000           $ 85,197,000 121,353,000  
AREC                    
Schedule of Equity Method Investments [Line Items]                    
Loss on deconsolidation of subsidiary             $ 1,600,000      
DIP amount outstanding   $ 400,000       $ 400,000     $ 400,000  
AREC | Disposal Group, Held-for-sale, Not Discontinued Operations                    
Schedule of Equity Method Investments [Line Items]                    
Loss on disposal           1,900,000        
Bencap LLC                    
Schedule of Equity Method Investments [Line Items]                    
Maximum borrowing amount         $ 1,500,000          
Income tax benefit                   800,000
Percentage of equity method investment               0.00%    
VestaCare, Inc.                    
Schedule of Equity Method Investments [Line Items]                    
Voting interest       3.00%            
Impairment of investments in unconsolidated affiliates           $ 2,500,000        
Percentage of equity method investment       15.00%       15.00%    
AREC                    
Schedule of Equity Method Investments [Line Items]                    
Receivable               $ 400,000    
Bencap LLC                    
Schedule of Equity Method Investments [Line Items]                    
Voting interest         30.00%          
Cash payment for acquisition         $ 2,200,000          
Recognized net loss from investment                   1,400,000
Impairment of investments in unconsolidated affiliates                   1,700,000
Losses from equity investment                   $ 500,000
Additional funding request     $ 500,000              
VestaCare, Inc.                    
Schedule of Equity Method Investments [Line Items]                    
Cash payment for acquisition       $ 2,500,000